What can we learn from negative results in clinical trials for proliferative vitreoretinopathy?

Bibliographic Details
Main Author: Peter Wiedemann
Format: Article
Language:English
Published: Press of International Journal of Ophthalmology (IJO PRESS) 2022-09-01
Series:International Journal of Ophthalmology
Online Access:http://ies.ijo.cn/en_publish/2022/9/20220901.pdf
_version_ 1828366446630010880
author Peter Wiedemann
author_facet Peter Wiedemann
author_sort Peter Wiedemann
collection DOAJ
first_indexed 2024-04-14T05:45:07Z
format Article
id doaj.art-bc31372b12c141a08a8e8271169eba76
institution Directory Open Access Journal
issn 2222-3959
2227-4898
language English
last_indexed 2024-04-14T05:45:07Z
publishDate 2022-09-01
publisher Press of International Journal of Ophthalmology (IJO PRESS)
record_format Article
series International Journal of Ophthalmology
spelling doaj.art-bc31372b12c141a08a8e8271169eba762022-12-22T02:09:19ZengPress of International Journal of Ophthalmology (IJO PRESS)International Journal of Ophthalmology2222-39592227-48982022-09-011591413141510.18240/ijo.2022.09.0120220901What can we learn from negative results in clinical trials for proliferative vitreoretinopathy?Peter Wiedemann0Peter Wiedemann. Medical Faculty, Leipzig University, Leipzig 04103, Germany. P@prwiedemann.dehttp://ies.ijo.cn/en_publish/2022/9/20220901.pdf
spellingShingle Peter Wiedemann
What can we learn from negative results in clinical trials for proliferative vitreoretinopathy?
International Journal of Ophthalmology
title What can we learn from negative results in clinical trials for proliferative vitreoretinopathy?
title_full What can we learn from negative results in clinical trials for proliferative vitreoretinopathy?
title_fullStr What can we learn from negative results in clinical trials for proliferative vitreoretinopathy?
title_full_unstemmed What can we learn from negative results in clinical trials for proliferative vitreoretinopathy?
title_short What can we learn from negative results in clinical trials for proliferative vitreoretinopathy?
title_sort what can we learn from negative results in clinical trials for proliferative vitreoretinopathy
url http://ies.ijo.cn/en_publish/2022/9/20220901.pdf
work_keys_str_mv AT peterwiedemann whatcanwelearnfromnegativeresultsinclinicaltrialsforproliferativevitreoretinopathy